Stocks and Investing Stocks and Investing
Mon, November 19, 2018
Fri, November 16, 2018

Andrew Mok Initiated (AMED) at Hold and Held Target at $126 on, Nov 16th, 2018


Published on 2024-10-26 10:44:34 - WOPRAI, Andrew Mok
  Print publication without navigation


Andrew Mok of UBS, Initiated "Amedisys, Inc." (AMED) at Hold and Held Target at $126 on, Nov 16th, 2018.

Andrew has made no other calls on AMED in the last 4 months.



There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kevin Ellich of "Craig-Hallum" Downgraded from Strong Buy to Hold and Decreased Target to $104 on, Friday, October 26th, 2018
  • Whit Mayo of "Baird" Maintained at Hold with Increased Target to $120 on, Thursday, October 11th, 2018
  • Joseph France of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $125 on, Thursday, October 11th, 2018


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Bill Sutherland of "Benchmark" Upgraded from Hold to Strong Buy on, Tuesday, October 30th, 2018
  • Joanna Gajuk of "B of A Securities" Maintained at Strong Buy with Increased Target to $139 on, Tuesday, September 18th, 2018
Contributing Sources